End-of-day quote
Other stock markets
|
||
- SEK | - |
Feb. 20 | Isofol Medical AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
Feb. 20 | Isofol Medical AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2021 | 22.41M 2.06M | Sales 2022 | 12.8M 1.18M | Capitalization | 120M 10.99M |
---|---|---|---|---|---|
Net income 2021 | -200M -18.39M | Net income 2022 | -160M -14.71M | EV / Sales 2021 | 49.7 x |
Net cash position 2021 | 378M 34.74M | Net cash position 2022 | 187M 17.16M | EV / Sales 2022 | -5.24 x |
P/E ratio 2021 |
-5.8
x | P/E ratio 2022 |
-0.75
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 62.57% |
Managers | Title | Age | Since |
---|---|---|---|
Petter Lindqvist
CEO | Chief Executive Officer | 72 | Jan. 08 |
Magnus Hurst
DFI | Director of Finance/CFO | 68 | Jan. 09 |
Roger Tell
CTO | Chief Tech/Sci/R&D Officer | 59 | 19-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Lars Erik Lind
CHM | Chairman | 83 | - |
Sten Nilsson
BRD | Director/Board Member | 76 | Jan. 03 |
Alain Herrera
BRD | Director/Board Member | 74 | 17-12-31 |
1st Jan change | Capi. | |
---|---|---|
+5.73% | 70.78B | |
+11.73% | 9.15B | |
-15.34% | 4.84B | |
+34.54% | 4.22B | |
+5.09% | 3.92B | |
+27.76% | 2.55B | |
-28.33% | 2.24B | |
-24.15% | 2.26B | |
+6.23% | 1.92B |